Key result
Blocking P2Y12 receptors or PI3Kbeta/gamma isoforms led to rapid disintegration of platelet aggregates, demonstrating that continuous signaling is required for dynamic thrombus stabilization.
Continuous outside-in signaling via P2Y12 and PI3K beta/gamma isoforms is required to maintain platelet aggregate stability, suggesting a mechanism for dynamic thrombus instability relevant to antiplatelet therapy.
Answers are grounded in this paper and cite their sources.
May inform antiplatelet strategies targeting thrombus instability; leaves open translation from animal models to clinical use.
Signaling from collagen and G protein-coupled receptors leads to platelet adhesion and subsequent thrombus formation. Paracrine agonists such as ADP, thromboxane, and Gas6 are required for platelet aggregate formation. We hypothesized that thrombi are intrinsically unstable structures and that their stabilization requires persistent paracrine activity and continuous signaling, maintaining integrin alpha(IIb)beta3 activation. Here, we studied the disassembly of human and murine thrombi formed on collagen under high shear conditions. Platelet aggregates rapidly disintegrated (1) in the absence of fibrinogen-containing plasma; (2) by blocking or inhibiting alpha(IIb)beta3; (3) by blocking P2Y12 receptors; (4) by suppression of phosphoinositide 3-kinase (PI3K) beta. In murine blood, absence of PI3Kgamma led to formation of unstable thrombi, leading to dissociation of multiplatelet aggregates. In addition, blocking PI3Kbeta delayed initial thrombus formation and reduced individual platelet-platelet contact. Similarly without flow, agonist-induced aggregation was reversed by late suppression of P2Y12 or PI3K isoforms, resulting in single platelets that had inactivated alpha(IIb)beta3 and no longer bound fibrinogen. Together, the data indicate that continuous outside-in signaling via P2Y12 and both PI3Kbeta and PI3Kgamma isoforms is required for perpetuated alpha(IIb)beta3 activation and maintenance of a platelet aggregate. This novel concept of intrinsic, dynamic thrombus instability gives possibilities for the use of antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
Cosemans et al. (2006) studied Thrombus formation. Blocking P2Y12 receptors or PI3K isoforms was evaluated on Thrombus disassembly. Blocking P2Y12 receptors or PI3Kbeta/gamma isoforms led to rapid disintegration of platelet aggregates, demonstrating that continuous signaling is required for dynamic thrombus stabilization.
Synapse has enriched 10 related papers. Consider them for comparative context: